Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate

INTRODUCTION: Our aim was to evaluate protein biomarker changes related to the administration of filgotinib, a Janus kinase (JAK) 1 preferential inhibitor, in patients with moderately to severely active rheumatoid arthritis (RA) with inadequate response to methotrexate. METHODS: Plasma and serum sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshiya, Taylor, Peter C., Elboudwarej, Emon, Hertz, Angie, Shao, Xiaorong, Malkov, Vladislav A., Matsushima, Hironori, Emoto, Kahaku, Downie, Bryan, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468462/
https://www.ncbi.nlm.nih.gov/pubmed/37490202
http://dx.doi.org/10.1007/s40744-023-00583-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468462/
https://www.ncbi.nlm.nih.gov/pubmed/37490202
http://dx.doi.org/10.1007/s40744-023-00583-9

Ejemplares similares